— Know what they know.
Not Investment Advice

STAB OTC

Statera Biopharma, Inc.
1W: -99.0% 1M: -99.5% 3M: -99.0% YTD: -99.7% 1Y: -99.0% 3Y: -99.9%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±54.3%
$-0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $7142 mcap · 48M float · 0.021% daily turnover · Short 45% of daily vol

📊 Key Metrics

TTM
$4M
Revenue
+1459.1% YoY
$-95M
Net Income
-650.2% YoY
$-13M
Free Cash Flow
+10.7% YoY
74.7%
Gross Margin
-230.6%
Op. Margin
-769.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-298.8%
ROA-172.3%
ROIC2085.4%

Valuation

P/E-0.0
P/B-0.0
EV/EBITDA-0.7

Leverage

Debt/Equity-0.72
Current Ratio0.05
Interest Cov.-1.8x

Quality Scores

Piotroski F3/9
Altman Z-22.62
Beneish M-33.47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms